2-pyrazinoylguanidine has been researched along with colforsin in 1 studies
Studies (2-pyrazinoylguanidine) | Trials (2-pyrazinoylguanidine) | Recent Studies (post-2010) (2-pyrazinoylguanidine) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
---|---|---|---|---|---|
18 | 5 | 0 | 13,460 | 46 | 1,298 |
Protein | Taxonomy | 2-pyrazinoylguanidine (IC50) | colforsin (IC50) |
---|---|---|---|
nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
A-Rahim, YI; Beyer, KH; Vesell, ES | 1 |
1 other study(ies) available for 2-pyrazinoylguanidine and colforsin
Article | Year |
---|---|
Studies on pyrazinoylguanidine. 3. Downregulation of lipolysis in isolated adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Colforsin; Cyclic AMP; Down-Regulation; Glycerol; Guanidines; Hypoglycemic Agents; In Vitro Techniques; Isoproterenol; Lipase; Lipolysis; Male; Pertussis Toxin; Pyrazines; Rats; Rats, Sprague-Dawley; Virulence Factors, Bordetella | 1996 |